BDSX - BIODESIX INC
18.78
2.920 15.548%
Share volume: 384,536
Last Updated: 03-06-2026
Healthcare/Services – Health:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$15.86
2.92
0.18%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-01-2024 | 03-03-2025 | 05-13-2025 | 11-03-2025 | 02-26-2026 | |
| Total revenue | 14.818 M | 17.925 M | 18.151 M | 20.429 M | 17.958 M | 21.768 M | 28.755 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 14.818 M | 17.925 M | 18.151 M | 20.429 M | 17.958 M | 21.768 M | 28.755 M | |
| 20.97% | 1.26% | 12.55% | -12.10% | 21.22% | 32.10% | |||
| Operating expenses | 22.596 M | 22.218 M | 22.563 M | 22.633 M | 23.318 M | 24.706 M | 25.842 M | |
| Selling general and admin | 20.556 M | 19.660 M | 20.016 M | 20.219 M | 20.448 M | 21.714 M | 22.972 M | |
| Research and development | 2.040 M | 2.558 M | 2.547 M | 2.414 M | 2.870 M | 2.992 M | 2.870 M | |
| Total expenses | 25.839 M | 26.162 M | 26.742 M | 27.078 M | 27.094 M | 28.819 M | 30.722 M | |
| 1.25% | 2.22% | 1.26% | 0.06% | 6.37% | 6.60% | |||
| Operating income | -11.021 M | -8.237 M | -8.591 M | -6.649 M | -9.136 M | -7.051 M | -1.967 M | |
| Ebit | -11.085 M | -8.624 M | -8.217 M | -6.499 M | -9.416 M | -6.642 M | -1.921 M | |
| Pretax income | -13.614 M | -10.808 M | -10.258 M | -8.251 M | -11.101 M | -8.716 M | -3.980 M | |
| -20.61% | -5.09% | -19.57% | 34.54% | -21.48% | -54.34% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -13.614 M | -10.808 M | -10.258 M | -8.251 M | -11.101 M | -8.716 M | -3.980 M | |
| 20.61% | 5.09% | 19.57% | -34.54% | 21.48% | 54.34% |